Edition:
United Kingdom

Ascendis Pharma A/S (ASND.OQ)

ASND.OQ on NASDAQ Stock Exchange Global Select Market

57.00USD
7:39pm GMT
Change (% chg)

$-2.00 (-3.39%)
Prev Close
$59.00
Open
$56.34
Day's High
$57.57
Day's Low
$54.16
Volume
59,191
Avg. Vol
36,574
52-wk High
$59.11
52-wk Low
$21.95

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.43 -1.039
Jun '17 0.44 -0.945
Mar '17 0.37 -0.775
FY 2016 Dec '16 1.04 -0.535
Sep '16 1.17 -0.724
Jun '16 1.14 -0.528
Mar '16 1.26 -0.817
 
*Note: Units in Millions ofEuro
**Note: Units in Euro

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 3 0.50 1.10 0.00 --
Quarter Ending Jun-18 3 0.50 1.10 0.00 --
Year Ending Dec-18 5 2.08 4.24 0.80 3.12
Earnings (per share)
Quarter Ending Mar-18 3 -0.77 -0.62 -0.89 --
Quarter Ending Jun-18 3 -0.78 -0.62 -0.91 --
Year Ending Dec-18 6 -3.17 -2.48 -3.53 -2.78
Sales and Profit Figures in Euro (EUR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 83.93 32.90
P/E High - Last 5 Yrs. -- 292.71 45.97
P/E Low - Last 5 Yrs. -- 91.44 24.37
Beta -- 0.90 0.89
Price to Sales (TTM) 367.07 110.72 5.77
Price to Book (MRQ) 7.85 13.56 5.41
Price to Tangible Book (MRQ) 9.04 14.02 6.98
Price to Cash Flow (TTM) -- 71.33 23.42
% Owned Institutions 64.55 12.89 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.66 5.21
Payout Ratio(TTM) -- 15.70 43.72

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -60.92 398.33 9.24
Sales (TTM) vs TTM 1 Yr. Ago -53.33 78.63 5.59
Sales - 5 Yr. Growth Rate -- 32.11 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago -79.01 25.10 19.65
EPS (TTM) vs TTM 1 Yr. Ago -40.57 -- --
EPS - 5 Yr. Growth Rate -- 38.95 10.73
Capital Spending - 5 Yr. Growth Rate -- 40.24 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.18
Current Ratio (MRQ) 8.54 5.30 2.97
LT Debt to Equity (MRQ) 0.00 22.82 12.22
Total Debt to Equity (MRQ) 0.00 24.47 16.52
Interest Coverage (TTM) -- -98.78 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.03 54.70
Gross Margin - 5 Yr. Avg. -- 51.06 52.42
EBITD Margin (TTM) -2,898.05 -- --
EBITD - 5 Yr. Avg -- -572.68 10.86
Operating Margin (TTM) -2,920.87 -717.10 4.64
Operating Margin - 5 Yr. Avg. -- -594.00 6.26
Pre-Tax Margin (TTM) -2,993.16 -691.66 5.44
Pre-Tax Margin - 5 Yr. Avg. -- -597.35 6.60
Net Profit Margin (TTM) -2,990.32 -692.88 1.76
Net Profit Margin - 5 Yr. Avg. -- -600.21 2.91
Effective Tax Rate (TTM) -- 22.57 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.19 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 35,176 22,602,121 855,667,832
Net Income/Employee (TTM) -1,051,866 2,968,747 100,655,557
Receivable Turnover (TTM) 7.19 20.14 5.78
Inventory Turnover (TTM) -- 2.36 3.35
Asset Turnover (TTM) 0.02 0.39 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -73.87 -1.05 10.98
Return on Assets - 5 Yr. Avg. -- -0.57 12.37
Return on Investment (TTM) -83.31 1.66 14.43
Return on Investment - 5 Yr. Avg. -- 2.23 16.18
Return on Equity (TTM) -83.31 2.58 16.13
Return on Equity - 5 Yr. Avg. -- 3.13 17.47
  1 Year 3 Year 5 Year
Sales % -43.26 -39.12 --
EPS (TTM) % -86.17 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Ascendis Pharma A/S

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 25.98 21.63 87 53
13 Week 27.10 20.91 79 62
26 Week 30.62 20.69 76 77
52 Week 78.77 51.52 84 50
YTD 76.83 55.29 81 56
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 83.57%
# of Holders: 81
Total Shares Held: 30,389,726
3 Mo. Net Change: 1,315,765
# New Positions: 23
# Closed Positions: 17
# Increased Positions: 48
# Reduced Positions: 33
# Net Buyers: 15
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.